1. Home
  2. WOLF vs HAE Comparison

WOLF vs HAE Comparison

Compare WOLF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

HOLD

Current Price

$56.58

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$73.70

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOLF
HAE
Founded
1987
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
WOLF
HAE
Price
$56.58
$73.70
Analyst Decision
Sell
Buy
Analyst Count
4
9
Target Price
$14.33
$84.13
AVG Volume (30 Days)
7.8M
1.0M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
$1,385,982,000.00
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.43
$5.23
P/E Ratio
N/A
$36.16
Revenue Growth
19.00
N/A
52 Week Low
$0.39
$47.32
52 Week High
$80.82
$87.32

Technical Indicators

Market Signals
Indicator
WOLF
HAE
Relative Strength Index (RSI) 54.83 61.31
Support Level $51.72 $48.98
Resistance Level $71.87 $86.72
Average True Range (ATR) 8.01 3.24
MACD -1.46 -0.15
Stochastic Oscillator 57.82 54.54

Price Performance

Historical Comparison
WOLF
HAE

About WOLF Wolfspeed Inc.

Wolfspeed Inc develops and manufactures semiconductor technologies based on silicon carbide (SiC) for power electronics applications. Its product portfolio includes SiC MOSFETs, Schottky diodes, and power modules used in power electronics applications. The company also provides reference designs, evaluation kits, and gate driver boards to support the development and integration of its SiC products across industries such as electric vehicles, renewable energy, and industrial systems.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: